This inventor holds 20 USPTO granted patents and 8 published patent applications, plus 4 CIPO patents and 10 EPO patents. Top assignees: Perlegen Sciences, Inc., University of Cambridge, Custom Millworking, Inc.. Active years: 2002-2021.
Location History:
- St. Germain, WI (US) (2007)
- Greensboro, NC (US) (2014 - 2018)
- Belmont, CA (US) (2002 - 2021)
Company Filing History:
8 out of 15 
4 out of 439 
1 out of 1 
Years Active: 2002-2021
Title: The Innovative Contributions of David R. Cox
Introduction
David R. Cox is a prominent inventor based in Belmont, California, known for his significant contributions to genomic analysis and cancer research. With a remarkable portfolio of 20 patents, he has made strides in understanding the genetic basis of diseases and drug responses.
Latest Patents
Among his latest patents, one focuses on "Computer systems and methods for genomic analysis." This invention relates to methods for identifying variations in the human genome and linking these variations to the genetic basis of disease and drug response. It emphasizes the identification of individual SNPs, the determination of SNP haplotype blocks and patterns, and the application of these findings in whole genome analysis. Another notable patent is centered on "Markers for breast cancer," which provides correlations between polymorphisms and breast cancer. This patent outlines methods for diagnosing, prognosing, and treating breast cancer, along with systems and kits designed for these purposes.
Career Highlights
David R. Cox has worked with several notable companies throughout his career, including Perlegen Sciences, Inc. and Cambridge Enterprise Limited. His work has significantly impacted the fields of genomics and oncology, showcasing his dedication to advancing medical science.
Collaborations
Throughout his career, David has collaborated with esteemed colleagues such as Bradley A. Margus and Dennis G. Ballinger, contributing to various innovative projects and research initiatives.
Conclusion
David R. Cox's work exemplifies the intersection of technology and medicine, particularly in genomic analysis and cancer research. His patents and collaborations reflect a commitment to improving healthcare through innovation.